{"id":59101,"date":"2024-03-26T01:02:53","date_gmt":"2024-03-26T00:02:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/"},"modified":"2024-03-26T01:02:53","modified_gmt":"2024-03-26T00:02:53","slug":"novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/","title":{"rendered":"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024"},"content":{"rendered":"<div>\n<p>EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.novabay.com%2F&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=NovaBay%26%23174%3B+Pharmaceuticals%2C+Inc.&amp;index=1&amp;md5=dc2d40e0ae1ec767a618770a398b5283\" rel=\"nofollow noopener\" shape=\"rect\">NovaBay<sup>\u00ae <\/sup>Pharmaceuticals, Inc.<\/a> (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwalignl bwwidth7\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n<b>Date\/Time<\/b><b>:<\/b><\/p>\n<\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTuesday, March 26, 4:30 p.m. ET \/ 1:30 p.m. PT<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwalignl bwwidth7\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwalignl bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwalignl bwnowrap bwwidth7\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n<b>Pre-Registration:<\/b><\/p>\n<\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nParticipants can pre-register for the conference call <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdpregister.com%2Fsreg%2F10186519%2Ffb9f3a0fb4&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=37790a05139e37c54d341874e228adb1\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwalignl bwwidth7\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwalignl bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwalignl bwwidth7\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwalignl bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nCallers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwalignl bwwidth7\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwalignl bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwalignl bwwidth7\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n<b>Dial In:<\/b><\/p>\n<\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nThose who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth7\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n833-816-1121 from within the U.S.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth7\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwwidth1\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth92\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n412-317-1862 from outside the U.S.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nThe live webcast of the conference call also will be available on the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.novabay.com%2Fevents%2F&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=Events&amp;index=3&amp;md5=d7edd4ba44bd2353dabcdfd70a68b356\" rel=\"nofollow noopener\" shape=\"rect\">Events<\/a> section of the Company website. A replay of the call will be available beginning two hours after its completion through April 16, 2024 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 1489846. The webcast will also be archived <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.novabay.com%2Fevents%2F&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=here&amp;index=4&amp;md5=345278add946f9e84fd97a2526b3bfee\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.<\/p>\n<p>\n<b>About NovaBay Pharmaceuticals, Inc:<\/b><\/p>\n<p>\nNovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare, skincare and wound care products. NovaBay\u2019s leading product Avenova\u00ae Antimicrobial Lid &amp; Lash Solution is often prescribed by eyecare professionals for blepharitis and dry-eye disease and is also available directly to consumers through online distribution channels such as Amazon.com. NovaBay also manufactures and sells effective, yet gentle and non-irritating wound care products. The PhaseOne\u00ae brand is distributed through commercial partners in the U.S. for professional use only, and the NeutroPhase\u00ae brand is distributed in China by China Pioneer Pharma Holdings, Limited. More information about NovaBay is available <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.novabay.com&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=here&amp;index=5&amp;md5=c01e1dc89001740b0a826ddf1907df69\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.<\/p>\n<p>\n<b><span class=\"bwuline\">Socialize and Stay Informed on NovaBay<\/span><\/b><span class=\"bwuline\">\u2019<\/span><b><span class=\"bwuline\">s Progress<br \/>\n<br \/><\/span><\/b>Like us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fnovabaypharma%2F&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=Facebook&amp;index=6&amp;md5=58bbf3e4df29a6591b7433f2ebdb839d\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a><br \/>Follow us on <a target=\"_blank\" href=\"https:\/\/twitter.com\/NovaBayPharma\" id=\"smartlink6\" rel=\"nofollow noopener\" shape=\"rect\">X<\/a><br \/>Connect with NovaBay on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fnovabay-pharmaceuticals%2F&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=7&amp;md5=f037e6a1705b35c503a732292e26b45e\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a><br \/>Visit NovaBay\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnovabay.com%2F&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=Website&amp;index=8&amp;md5=b444dd888d1c8a0aa756cfec6ef9d07e\" rel=\"nofollow noopener\" shape=\"rect\">Website<\/a><\/p>\n<p>\n<b><span class=\"bwuline\">Avenova Purchasing Information<br \/>\n<br \/><\/span><\/b>For NovaBay Avenova purchasing information:<br \/>\n<br \/>Please call 800-890-0329 or email <a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;:sa&#x6c;&#x65;&#x73;&#x40;&#97;&#118;eno&#x76;&#x61;&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">sa&#108;&#101;&#x73;&#x40;&#x61;&#x76;en&#111;&#118;&#x61;&#x2e;&#x63;&#x6f;m<\/a><br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.avenova.com&amp;esheet=53915180&amp;newsitemid=20240325019136&amp;lan=en-US&amp;anchor=Avenova.com&amp;index=9&amp;md5=2b615a1e3f9c3351515010808afa030d\" rel=\"nofollow noopener\" shape=\"rect\">Avenova.com<\/a><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b><span class=\"bwuline\">NovaBay Contact<\/span><\/b><br \/>Justin Hall<br \/>\n<br \/>Chief Executive Officer and General Counsel<br \/>\n<br \/>510-899-8800<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;&#106;hal&#x6c;&#x40;&#x6e;&#x6f;&#x76;&#97;&#98;&#97;y&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#106;&#x68;a&#108;&#x6c;&#64;&#110;&#x6f;v&#x61;&#x62;&#97;&#x79;&#46;&#99;&#x6f;m<\/a><\/p>\n<p><b><span class=\"bwuline\">Investor Contact<\/span><\/b><br \/>LHA Investor Relations<br \/>\n<br \/>Jody Cain<br \/>\n<br \/>310-691-7100<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;o:&#x6a;&#x63;&#x61;&#105;&#110;&#64;l&#x68;&#x61;&#x69;&#46;&#99;om\" rel=\"nofollow noopener\" shape=\"rect\">&#106;&#x63;&#97;&#x69;n&#64;&#x6c;&#104;&#x61;i&#x2e;c&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;NovaBay\u00ae Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date\/Time: \u00a0 Tuesday, March 26, 4:30 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59101","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;NovaBay\u00ae Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date\/Time: \u00a0 Tuesday, March 26, 4:30 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-26T00:02:53+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024\",\"datePublished\":\"2024-03-26T00:02:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\\\/\"},\"wordCount\":402,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\\\/\",\"name\":\"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2024-03-26T00:02:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/","og_locale":"en_US","og_type":"article","og_title":"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 - Pharma Trend","og_description":"EMERYVILLE, Calif.&#8211;(BUSINESS WIRE)&#8211;NovaBay\u00ae Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date\/Time: \u00a0 Tuesday, March 26, 4:30 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/","og_site_name":"Pharma Trend","article_published_time":"2024-03-26T00:02:53+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024","datePublished":"2024-03-26T00:02:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/"},"wordCount":402,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/","url":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/","name":"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2024-03-26T00:02:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/novabay-pharmaceuticals-to-hold-2023-fourth-quarter-and-full-year-conference-call-on-march-26-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59101"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59101\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}